Extended Cessation Treatment for Teen Smokers

Completed · Phase 2/Phase 3

Conditions studied: Nicotine Dependence

In brief

This study is designed to test the efficacy of an extended smoking cessation program for teen smokers. We hypothesize that teen smokers randomized to extended treatment will have a higher abstinence rate at 52 week follow-up than teen smokers receiving only open label treatment.

Key facts

Study ID

NCT00459953

Run by

Stanford University

People needed

141

Starts

2006-09-01

Expected to finish

2011-07-01

Last updated by the study team

2016-05-30

Who can join

Age: 14 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 14-18 at the beginning of the study
• Smoking at least 10 cigarettes per day
• At least one quit attempt in previous 6mos

You may not qualify if…

• Current DSM-IV disorder (depression, panic disorder, social anxiety disorder and agoraphobia)
• Current self report of daily or heavy use (more than three times per week) of any drugs (marijuana, alcohol, cocaine, opiates, stimulants, etc.)
• Positive urine pregnancy test
• Currently on bupropion (Wellbutrin, Wellbutrin SR, Zyban) or other antidepressants, MAOI's, antipsychotics, benzodiazepines
• Currently on NRT
• Currently receiving formal treatment for substance abuse problem, depression or anxiety

Where it is running

• Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.